Microbix Biosystems Inc (TSE:MBX)’s share price was down 7.7% on Wednesday . The stock traded as low as C$0.24 and last traded at C$0.24, approximately 108,411 shares traded hands during mid-day trading. An increase of 35% from the average daily volume of 80,319 shares. The stock had previously closed at C$0.26.

The company has a debt-to-equity ratio of 66.33, a quick ratio of 0.39 and a current ratio of 1.35. The company has a market cap of $20.85 million and a P/E ratio of -2.95. The stock has a 50-day moving average of C$0.23 and a two-hundred day moving average of C$0.24.

Microbix Biosystems Company Profile (TSE:MBX)

Microbix Biosystems Inc, a life science company, manufactures viral and bacterial antigens and reagents for the diagnostics industry worldwide. The company produces infectious disease antigens, including viral, bacterial, and parasitic products, which are used in various applications, such as immunodiagnostic assays comprising ELISA, chemiluminescent automated immunoassays, immunohistochemistry, immunofluorescence, latex agglutination, rapid tests, and flow cytometry; controls for diagnostic assays.

Featured Article: Pattern Day Trader – What is the PDT Rule?

Receive News & Ratings for Microbix Biosystems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Microbix Biosystems and related companies with MarketBeat.com's FREE daily email newsletter.